Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures fall as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
Merck (MRK) Wins Bid to Revive NuvaRing Patent Case Against Teva (TEVA) - Bloomberg
October 19, 2017 10:18 AM EDTMerck (NYSE: MRK) won a bid to revive a NuvaRing patent case against Teva Pharma (NYSE: TEVA), according to Bloomberg. A federal judge erred in ruling the patent for vaginal ring is invalid, said the U.S. Court of Appeals for the Federal Circuit in an opinion.
... More


